Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Mursla Bio
Entity

Mursla Bio

Tracked across 1 events · 7 articles · First seen Mar 04, 2026 · Last active Mar 04, 2026

Sentiment
70
Attention
4
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Business
Mursla Bio Joins ABHI US Accelerator
Mursla Bio has been selected to join the Association of British HealthTech Industries (ABHI) US Accelerator, which will provide structured access to the US market for its EvoLiver liver cancer surveillance test. This program is expected to accelerate EvoLiver's path into clinical workflows and support its early adoption across specialist hepatology centers.
Mar 04, 2026 · 7 articles
Relationships (4)
BD (company) advisor ↔ Mursla Bio BD (company) provides operational guidance to Mursla Bio through the ABHI progra
Pierre Arsène CEO ↔ Mursla Bio Pierre Arsène is the Founder and CEO of Mursla Bio.
Association of British HealthTech Industries ↔ Mursla Bio Unknown
United States===Dell Medical School at the University of Texas advisor ↔ Mursla Bio United States===Dell Medical School at the University of Texas provides operatio
NEWSDESK
Track Mursla Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.